Process for purifying coagulation factor VIII using DEAE-crosslinked
dextran
    1.
    发明授权
    Process for purifying coagulation factor VIII using DEAE-crosslinked dextran 失效
    使用DEAE交联的葡聚糖纯化凝血因子VIII的方法

    公开(公告)号:US4093608A

    公开(公告)日:1978-06-06

    申请号:US783625

    申请日:1977-04-01

    摘要: A process for purifying coagulation factor VIII which comprises contacting a plasma or a plasma fraction containing prothrombin complex and coagulation factor VIII (antihemophilic factor A) with diethylaminoethyl-crosslinked dextran to adsorb and remove the prothrombin complex from said plasma or plasma fraction. Coagulation factor VIII thus obtained can be administered to control the bleeding in hemophilia A patients.

    摘要翻译: 一种用于纯化凝血因子VIII的方法,其包括将含有凝血酶原复合物的血浆或血浆部分和凝血因子VIII(抗血友病因子A)与二乙基氨基乙基交联的葡聚糖接触以从所述血浆或血浆级分中吸附和去除凝血酶原复合物。 这样获得的凝血因子VIII可以用于控制血友病A患者的出血。